MedLumics

Private

MadridHealthcare & Life Scienceshttps://medlumics.com/

Last Round

VC Round

Jul 29, 2024

Total Funding Raised

$66.11M

Company Overview

MedLumics is a medical device company developing AblaView, an optically-guided real-time ablation catheter system for the treatment of Atrial Fibrillation.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Medical Imaging, Clinical Trials

Business Model

B2B

Customer Profile

Hardware Sales

AI Layer

Application

Keywords

cardiac ablationatrial fibrillationpulsed field ablationPFAoptical coherence reflectometryOCRelectrophysiologycatheter systembiophotonic technologycardiac arrhythmialesion assessmentmedical devicemedtechEP labclinical trials

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

MedLumics Comps

Public and private peers based on sector, stage, and business model.

MedLumics comps — public and private peers by sector, stage, and business model
Company	Status	Est. Valuation	Rev Multiple
OpenAI	Private	$86.0B	~40x
Cohere	Private	$5.0B	--
Competitor 1	Public	$XX.XB	XXx
Competitor 2	Public	$XX.XB	XXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

MedLumics Funding Rounds

Historical fundraising activity

Data table
Round	Date	Amount Raised	Valuation	Investors	Sources
VC Round	Jul 29, 2024
VC Round	Feb 13, 2024
Series E	Feb 10, 2021
Grant	May 1, 2019
Series B	Mar 20, 2017
Series A	Dec 1, 2011

View all Funding Rounds

Key People

Founding team and executive leadership

James Greene

Chief Executive Officer

Executive Team

MedLumics Investors

Notable investors and investment history

MedLumics investors
Investor	Rounds
Asabys Partners	VC Round, Series E
CDTI Innvierte	Series E
Seroba Life Sciences	Series B
Andera Partners	Series E, Series B
European Commission	Grant
Ysios Capital	Series B, Series A
Innogest Capital	Series B, Series E

View all Investors

MedLumics Filings

SEC and related filings with document metadata.

Data table
Typed	Date	Amount Offered	Amount Sold	Filling	Pages	Download
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation

MedLumics Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about MedLumics's valuation, stock price, and market status.

Firmographic Details

HeadquartersMadrid

Employee Range13

Year Founded2009

Last FundingJul 29, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.